Articles from Sub-Q Bionics

Sub-Q Bionics Announces Licensing Agreement to Advance Lymphedema Care
Sub‑Q Bionics, a medical device company developing an innovative implantable lymphatic drainage system designed to help patients living with lymphedema better manage their symptoms, today announced a licensing agreement with Mayo Clinic.
By Sub-Q Bionics · Via Business Wire · March 17, 2026
Articles from Sub-Q Bionics | MarketMinute